Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort in Smoking Asthmatics
NCT00691951Phase 3Completed
- Sponsor
- Université Laval
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of formoterol in asthma (2 arms), sponsored by Université Laval. Primary endpoint: Asthma Control Questionnaire at 2 months. Status: completed.
02
Drugs
formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00691951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00691951.